FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220892016> ?p ?o ?g. }

• W4220892016 endingPage "06" @default.
• W4220892016 startingPage "P3" @default.
• W4220892016 abstract "Abstract Background Taxane-based chemotherapy is first line treatment in various cancers, including premenopausal breast cancer, but the inter-individual effectiveness is unpredictable. Differences in expression and activity of docetaxel-metabolizing enzymes and transporters (DMETs) may modify docetaxel effectiveness. Although reported data are inconsistent, some findings suggests that variant alleles that reduce the function of 1) SLC-transporters reduce drug influx into hepatocytes; 2) CYP-450 enzymes hamper drug metabolism; and 3) ABC-transporters decrease docetaxel clearance. The net effect is hypothesized to be increased docetaxel exposure and effectiveness. In contrast, GSTP1 variants have been associated with poorer docetaxel effectiveness. We investigated whether single nucleotide polymorphisms (SNPs) in drug metabolizing enzymes and transporters were associated with mortality in premenopausal breast cancer patients. Materials and methods Using the Danish Breast Cancer Group (DBCG) clinical database, we identified data on premenopausal women aged 18–55 years, diagnosed with non–metastatic breast cancer during 2007–2011. All women were recommended epirubicin, cyclophosphamide and docetaxel-based adjuvant chemotherapy, and tamoxifen if the disease was estrogen receptor (ER) positive. From DBCG and other Danish administrative and medical registries we retrieve data on death, emigration, and tumor characteristics. We collected archived formalin-fixed paraffin-embedded primary tumor tissue from Danish pathology departments. We genotyped 17 candidate SNPs using TaqMan SNP genotyping assays and, for each SNP, categorized the women as having two normal alleles (wildtype) or at least one variant allele. We followed the women from six months after breast cancer diagnosis until death, emigration or 30th June 2019, whichever came first. Comparing variant carriers with wildtype, we computed cumulative incidence proportions (CIPs) and used Poisson regression models to calculate unadjusted incidence rate ratios (IRRs) and associated 95% confidence intervals (CIs) of all–cause mortality. We stratified by ER status to evaluate interaction. Analyses were repeated for breast cancer specific mortality. Results Our cohort included 2,262 women. During follow–up (median 9.6 years, interquartile range: 8.4–11.0), 250 women died (CIP: 14%); 219 due to breast cancer (CIP: 11%). Genotyping was successful for ≥95% of the study cohort, with exception of two SNPs, which were excluded from analyses. We detected decreased mortality in variant carriers of SLCO1B1 rs2306283 (IRR: 0.75, 95% CI 0.58–0.97), and ABCB1 rs1128503 (IRR: 0.81, 95% CI: 0.63–1.05), ABCB1 rs2032582 (IRR: 0.80, 95% CI: 0.62–1.04) and ABCC2 rs12762549 (IRR: 0.80, 95% CI: 0.62–1.04). In contrast, mortality was increased in carriers of GSTP1 rs1138272 (IRR: 1.28, 95% CI: 0.93–1.76) and, unexpectedly, in carriers of CYP3A rs10273424 (IRR: 1.36, 95% CI: 0.99–1.86) variant carriers. Sensitivity analyses yielded similar findings. ER status did not modify the associations. Conclusions In this study, mortality may be associated with SNPs in ABCB1, ABCC2, SLCO1B1, CYP3A and GSTP1 in premenopausal women with non-metastatic breast cancer receiving docetaxel. The mechanisms underlying our findings remains unclear but may be related to docetaxel pharmacokinetics. Citation Format: Cathrine F Hjorth, Per Damkier, Tore B Stage, Søren Feddersen, Bent Ejlertsen, Timothy L Lash, Stephen Hamilton-Dutoit, Thomas P Ahern, Mikael Rørth, Henrik T Sørensen, Deirdre Cronin-Fenton. Single nucleotide polymorphisms and mortality after docetaxel-based chemotherapy in premenopausal breast cancer: A population-based cohort study in Denmark [abstract]. In: Proceedings of the 2021 San Antonio Breast Cancer Symposium; 2021 Dec 7-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2022;82(4 Suppl):Abstract nr P3-13-06." @default.
• W4220892016 created "2022-04-03" @default.
• W4220892016 creator A5005287400 @default.
• W4220892016 creator A5029319079 @default.
• W4220892016 creator A5033040903 @default.
• W4220892016 creator A5034630560 @default.
• W4220892016 creator A5039413618 @default.
• W4220892016 creator A5053033359 @default.
• W4220892016 creator A5066076502 @default.
• W4220892016 creator A5072067165 @default.
• W4220892016 creator A5079241058 @default.
• W4220892016 creator A5079564960 @default.
• W4220892016 creator A5089674534 @default.
• W4220892016 date "2022-02-15" @default.
• W4220892016 modified "2023-10-18" @default.
• W4220892016 title "Abstract P3-13-06: Single nucleotide polymorphisms and mortality after docetaxel-based chemotherapy in premenopausal breast cancer: A population-based cohort study in Denmark" @default.
• W4220892016 doi "https://doi.org/10.1158/1538-7445.sabcs21-p3-13-06" @default.
• W4220892016 hasPublicationYear "2022" @default.
• W4220892016 type Work @default.
• W4220892016 citedByCount "0" @default.
• W4220892016 crossrefType "journal-article" @default.
• W4220892016 hasAuthorship W4220892016A5005287400 @default.
• W4220892016 hasAuthorship W4220892016A5029319079 @default.
• W4220892016 hasAuthorship W4220892016A5033040903 @default.
• W4220892016 hasAuthorship W4220892016A5034630560 @default.
• W4220892016 hasAuthorship W4220892016A5039413618 @default.
• W4220892016 hasAuthorship W4220892016A5053033359 @default.
• W4220892016 hasAuthorship W4220892016A5066076502 @default.
• W4220892016 hasAuthorship W4220892016A5072067165 @default.
• W4220892016 hasAuthorship W4220892016A5079241058 @default.
• W4220892016 hasAuthorship W4220892016A5079564960 @default.
• W4220892016 hasAuthorship W4220892016A5089674534 @default.
• W4220892016 hasConcept C104317684 @default.
• W4220892016 hasConcept C121608353 @default.
• W4220892016 hasConcept C126322002 @default.
• W4220892016 hasConcept C135763542 @default.
• W4220892016 hasConcept C143998085 @default.
• W4220892016 hasConcept C153209595 @default.
• W4220892016 hasConcept C2777176818 @default.
• W4220892016 hasConcept C2781190966 @default.
• W4220892016 hasConcept C2908647359 @default.
• W4220892016 hasConcept C530470458 @default.
• W4220892016 hasConcept C54355233 @default.
• W4220892016 hasConcept C71924100 @default.
• W4220892016 hasConcept C86803240 @default.
• W4220892016 hasConcept C99454951 @default.
• W4220892016 hasConceptScore W4220892016C104317684 @default.
• W4220892016 hasConceptScore W4220892016C121608353 @default.
• W4220892016 hasConceptScore W4220892016C126322002 @default.
• W4220892016 hasConceptScore W4220892016C135763542 @default.
• W4220892016 hasConceptScore W4220892016C143998085 @default.
• W4220892016 hasConceptScore W4220892016C153209595 @default.
• W4220892016 hasConceptScore W4220892016C2777176818 @default.
• W4220892016 hasConceptScore W4220892016C2781190966 @default.
• W4220892016 hasConceptScore W4220892016C2908647359 @default.
• W4220892016 hasConceptScore W4220892016C530470458 @default.
• W4220892016 hasConceptScore W4220892016C54355233 @default.
• W4220892016 hasConceptScore W4220892016C71924100 @default.
• W4220892016 hasConceptScore W4220892016C86803240 @default.
• W4220892016 hasConceptScore W4220892016C99454951 @default.
• W4220892016 hasIssue "4_Supplement" @default.
• W4220892016 hasLocation W42208920161 @default.
• W4220892016 hasOpenAccess W4220892016 @default.
• W4220892016 hasPrimaryLocation W42208920161 @default.
• W4220892016 hasRelatedWork W1771722205 @default.
• W4220892016 hasRelatedWork W2015092588 @default.
• W4220892016 hasRelatedWork W2027175481 @default.
• W4220892016 hasRelatedWork W2057553101 @default.
• W4220892016 hasRelatedWork W2085008897 @default.
• W4220892016 hasRelatedWork W2126511903 @default.
• W4220892016 hasRelatedWork W2172254302 @default.
• W4220892016 hasRelatedWork W2464051959 @default.
• W4220892016 hasRelatedWork W2598177251 @default.
• W4220892016 hasRelatedWork W2998725311 @default.
• W4220892016 hasVolume "82" @default.
• W4220892016 isParatext "false" @default.
• W4220892016 isRetracted "false" @default.
• W4220892016 workType "article" @default.